ABSTRACT
INTRODUCTION
The expression of proteins in microorganisms is a powerful tool for basic research and for various medical and industrial needs. A variety of advanced expression systems have been developed in prokaryotes, in particular in the bacterium Escherichia coli (9, 20, 28) . In this organism, a foreign protein can be expressed efficiently, reaching a level of 10%-30% of its total protein content (7, 9, 20, 28) . However, many eukaryotic proteins expressed in bacteria are not active. For various reasons, proteins expressed in bacteria must be extensively purified and assayed in rigorous and expensive quality-control systems. Therefore, although powerful, the bacterial systems are disadvantageous in many cases (3, 27) .
An attractive alternative is the baker's yeast, Saccharomyces cerevisiae . Most foreign proteins expressed in this eukaryote are accurately processed posttranslationally and are biologically active (3, 10, 21, 27) . S. cerevisiaehas been widely used in the food industry and is regarded as a safe organism; the risk of side effects and the odds of the presence of pathogenic agents are minimal (3, 10, 27) . Although S. cerevisiae was used successfully for the production of several proteins for therapeutic and diagnostic uses (10) , and in spite of its great potential as a protein factory, this organism is not widely used for the production of proteins. The major reason for this seems to be that the level of expression obtained in yeast is significantly lower than that obtained in bacteria (3, 10, 21, 23, 24) .
Only a few yeast expression vectors are available. All vectors (including bacterial and mammalian vectors) contain strong promoters (usually a promoter of a glycolitic gene; e.g., GPD1 , ADH1or PGK1 ) (21, 23, 24) . In addition, they contain the 2 µ m origin of replication or a multicopy integration system that promotes maintenance of the vector in 60-100 copies per cell (10, 22) . Some of the vectors contain an inducible promoter, the most widely used being the GAL1-10 promoter (21, 23) . The strategy of all yeast expression vectors is therefore based on a high transcription rate and the presence of many copies per cell.
Most yeast expression vectors are present in the cell as nonintegrated plasmids. This forces the growth of expressing cultures on synthetic media under selective conditions. When grown in laboratory flasks, these cultures enter the stationary phase at a low cell density, and the quantities of proteins obtained are low. When grown in industrial fermentors, high cell concentrations could be obtained but would require special treatments and long, expensive incubation time.
Here, we describe the development and use of a novel type of expression vector that is fully inducible and can be used in rich media. This vector is based on the regulatory elements of the GCN4 gene. GCN4encodes a transcriptional activator with target genes that encode amino acids and nucleotides biosynthetic enzymes (15, 16) . Under optimal growth conditions on media supplemented with amino acids and pyrimidine and purine bases, Gcn4 is not expressed. When cells are starved for amino acids, Gcn4 expression is dramatically induced, and consequently, transcription of biosynthetic genes commences. The expression of Gcn4 is mainly regulated at the translational level. The mRNA levels of GCN4are high under most growth conditions, but the translation rate of this mRNA is extremely low (17) . The low translation rate is maintained by four short open reading frames (ORFs) located at the 5 ′ noncoding leader of the message (upstream ORFs 1-4; 4uORF) (4, (15) (16) (17) (Figure 1 ). Ribosomes recognize uORF1 and begin translation, yet they dissociate from the mRNA at the stop codon and reinitiate translation at another short ORF. In most cases, ribosomes do not reach the fifth ORF, which is the GCN4coding sequence (17) . The inhibition of GCN4transla -tion depends on the high rate of reinitiation. Under amino acid starvation, the rate of reinitiation is reduced to a minimum, and consequently, translation activity in the cell pauses, which is an obvious protective response. Reduction in reinitiation activity is mediated by the Gcn2 kinase that phosphorylates, and thereby inhibits, the activity of initiation factor 2 α(eIF2 α ) (4, 17) . Although translation in the cell is generally ceased under these conditions, translation of GCN4mRNA is specifically induced (15) (16) (17) . This activity seems a logical response because the Gcn4 protein is required for the induction of amino acid biosynthesis. Following the translation of Gcn4 and the synthesis of amino acids, general translation activity restarts. In the laboratory, amino acid starvation could be easily mimicked by the treatment of yeast cells with inhibitors of biosynthetic enzymes. The most widely used compound is 3-amino-1,2,4-triazole (3-AT), a competitive inhibitor of His3. Cells combat the competitive inhibition effect simply by producing more His3. The GCN4 translation rate, which leads to HIS3tran -scription, dramatically increases in response to 3-AT treatment (12, 15) .
We proposed that the unusual pattern of Gcn4 expression could be advantageous for the expression of a foreign protein. We reasoned that if the mRNA of a given foreign protein is selectively translated when translation of most cellular mRNAs is halted, its concentration should be high. To test this idea, we have cloned the regulatory elements of GCN4(from -1067 to -1; +1 is the initiation of translation) and ligated this fragment to the coding sequence of the human serum albumin ( HSA ) gene. We show that under the control of GCN4regulatory elements, expression of HSA is rapidly and efficiently induced by 3-AT. We further show that induction occurs at the translational level and could be finely controlled by using various 3-AT concentrations. Importantly, this vector induces efficient expression as an integrated copy, which allows growth on rich media to high cell density.
MATERIALS AND METHODS

Yeast Strains and Growth Conditions
The SP1 strain ( MATa , his3 , leu2 , ura3 , trp1 , ade8 , can r ; obtained from M. Wigler) (18) was used as a source of genomic DNA from which the GCN4 upstream sequences were cloned. Strain BJ2168 ( MATa , prc1-407 , prb1-1122 , pep4-3 , leu2 , trp1 , ura3-52 ; obtained from the yeast genetic stock center at the University of California-Berkeley) (29) was used as a host for the expression plasmids. Yeast cultures were grown on either 1% yeast extract, 2% bactopeptone, 2% glucose (YPD medium) or 0.17% yeast nitrogen base without amino acids and ammonium sulfate (Difco, Detroit, MI, USA), 0.5% NH 4 (SO 4 ) 2 , 2% glucose and the required amino acids and uracil (40 mg/L) (SD medium). Strains that harbor plasmids were grown on SD(-uracil). For expression experiments, cultures were harvested at the logarithmic phase (unless mentioned otherwise) and resuspended in SD(-uracil, -histidine) [or in SD(-histidine) for integrated vectors], supplemented with 3-AT (see details of each experiment).
PCR Cloning of GCN4Fragments and Plasmid Constructions
PCRs were performed using genomic DNA of the yeast strain SP1 as a template and the following primers. Primer 3 ′ (5 ′ -GCGCCGGATCCTTTA-TTTGTATTTAATTTATTTTCTTG-AGC-3 ′ ) contains a BamHI site and was used in all PCRs ( Figure 1 ). The long promoter (5 ′ -GCGCCGACTAGT -TTGCCACGTACATGACATTA-3 ′ ) was used to amplify the sequence from -1067. The middle-sized promoter (5 ′ -GCGCCGACTAGTGCCGAACACC -ACCGGCATCTTG-3 ′ ) was used to amplify the sequence from -904. The short promoter (5 ′ -GCGCCGACTAG-TCGGAAGATAAATACTCCAAC-3 ′ ) was used to amplify the sequence from -706. These three primers contain Spe I sites. They were used at the 5 ′ side of the GCN4promoter (Figure 1 ). PCR products were digested with Spe I and BamHI and ligated to pBluescript ® (Stratagene, La Jolla, CA, USA) to obtain pBSG-Short (pBSG-S), pBSGMiddle (pBSG-M) and pBSG-Long (pBSG-L). The cloned DNAs were sequenced and found to be identical to the sequence of this region as it appears in the Saccharomyces genome database.
To ligate the coding sequence of HSAdownstream from the GCN4se -quences, the cDNA of HSAwas cloned as a BamHI-Eco RI fragment to pBSG-S, pBSG-M and pBSG-L. These chimeric genes contained about 70 bp of 5 ′ UTR sequences of HSA , which were found to reduce the expression level (data not shown). To remove this sequence from each of the three plasmids, a 885 bp BamHI-Nco I fragment that contains the entire 5 ′ UTR and 815 bp of the HSAcoding sequence was replaced with a 815 bp PCR product that contains only the first 815 bp of the HSAcoding sequence. Primers used for this PCR were HSA-ATG (5 ′ -GCG-CGCGGATCCATGAAGTGGGTAA-CCTTTATTTCCC-3 ′ ) and HSA-815
The plasmids obtained were designated pBSG-S-HSA, pBSG-M-HSA and pBSG-L-HSA. The GCN4 -HSA moiety of each of these plasmids was removed as a Spe I-Eco RI fragment and inserted into pRS316 (a centromeric yeast plasmid) (25) , pRS306 (an integrated yeast vector) (25) and pRS426 (a 2 µ m-based vector) (2) . The terminator of ADHI (0.6 kb Eco RI fragment) was ligated to the Eco RI site of each of the nine plasmids obtained. The final constructs were designated as follows: (i) pGES306-S-HSA (for GCN4 -based expression system, derived from pRS306, which contains the short GCN4pro -moter and the HSA cDNA; (ii) pGES306-M-HSA, which is similar to pGES306-S-HSA but contains the medium- Integrated vectors were digested with Stu I before yeast transformation. This digestion directs the vector to the URA3locus of the genome. To express HSA under the ADH1 promoter, a BamHI-Eco RI fragment containing the HSA cDNA was rendered blunt by DNA Pol I (Klenow fragment) and inserted into the Sma I site of pAD4 ∆(1).
Western Blot Analysis
Protein extracts were prepared as previously described (8) . From each extract, 30 µ g were used for Western blot analysis. The SDS-PAGE gels contained 10% acrylamide. Protein blotting was performed with a semi-dry blotter (LKB, Sweden) for 2 h under constant current (mA = 0.8 × gel area in cm 2 ). Polyclonal anti-HSA antibodies (RAHu/albumin) were purchased from Nordic Immunology (Tilburg, The Netherlands) and used in a dilution of 1:50 000. Peroxidase-conjugated goat anti-rabbit antibodies were purchased from Jackson ImmunoResearch Laboratories (West Grove, PA, USA) and used at the dilution of 1:25 000. Puri -
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Vol. 28, No. 3 (2000) Figure 2 . The basic pGES family containing the HSAcDNA. Note that pGES306-HSA is an integrative vector, pGES316-HSA is a centromeric vector and pGES426-HSA is a multicopy vector. All vectors shown contain the long GCN4 promoter (see text for details).
fied HSA (Sigma, St. Louis, MO, USA) was used as a standard positive control. RNA preparations and primer extension analysis were performed as previously described (6) using the following primers: HSA-extension (5 ′ -A-CCTCACTCTTGT-GTGCATCTC-3 ′ ) and GCN4-extension (5 ′ -ATAATTC -GCTAGTGAAACTGATGGGC-3 ′ ).
Primer extension products were separated on 6% acrylamide 7 M urea gel.
RESULTS AND DISCUSSION
A 1067 bp Fragment of the GCN4 Upstream Sequences is Required for Efficient Expression of a Heterologous Gene
To test whether regulatory elements of GCN4could be used to regulate the expression of a heterologous gene, we cloned a DNA fragment that resides upstream from the GCN4 coding sequence. Initially, we cloned (from a genomic DNA prepared from the SP1 strain) a fragment (-706 to -1, designated short promoter; see Materials and Methods and Figure 1 ) previously shown to be sufficient for regulated expression of Gcn4 and of a GCN4 / β -galactosidase ( β -gal) chimeric gene (containing 53 amino acids of Gcn4 fused to β -gal) (13, 14) . The capability of this 706 bp fragment alone (containing no GCN4coding sequences) to control the transcription and translation of another gene has not been reported. We constructed a GCN4 -S-HSA (S stands for short promoter; see Materials and Methods) cassette that was introduced into a multicopy yeast plasmid as well as into centromeric and integrated plasmids. The terminator of the ADH1gene was inserted downstream to GCN4 -S-HSA . The resulting plasmids were introduced into yeast cells that were subsequently grown under various conditions, including amino acid starvation and 3-AT treatment.
Protein extracts were prepared from the cultures, and the expression of HSA was monitored by Western blot analysis. Unexpectedly, in all cases, the expression of HSA was not detectable (data not shown). Therefore, we further cloned two longer fragments of GCN4 upstream sequences, one containing the sequence from -904 to -1 and another containing the sequence from -1067 to -1 (designated middle-sized and long promoters, respectively; see Figure 1 and Materials and Methods). When the HSAgene was ligated to these fragments (plasmids pGES-M-HSA and pGES-L-HSA) and introduced into yeast cells, a high expression level of HSA was detected (Figure 3) . Note that an additional band of 45 kDa cross-reacted with anti-HSA antibodies. This band, which is a result of proteolytic activity of the Yap3 protease (19) , was observed also by others that expressed HSA in yeast (19, 26) .
In all constructs, HSA expression was barely detectable before induction with 3-AT, which suggests that expression from pGES plasmids is tightly controlled. Expression from constructs containing the long promoter was usually higher than that obtained with the middle-sized promoter (note, for example, the level of expression after 10 h induction; see Figure 3 ). All further experiments were carried out with the long promoter.
Expression of HSA Under GCN4 Regulatory Elements Is Induced by 3-AT
We tested whether the cloned GCN4 elements regulate HSA expression in a pattern similar to that of Gcn4 regulation. Yeast cells (strain BJ2168) that harbor pGES426-L-HSA were grown to logarithmic phase on SD(-uracil). Then, cells were collected and resuspended in SD(-uracil, -histidine) medium supplemented with 20 mM 3-AT. The samples were removed from the culture at indicated time points, and the expression of HSA was measured. Two hours after the addition of 3-AT, the expression of HSA was easily detected. The expression reached its maximum level between 6 and 8 h after induction ( Figure 4A ). These results (Figure 3 and Figure 4A) show that a vector based on GCN4upstream elements is useful for the inducible expression of foreign genes.
To test whether the level of expression could be finely controlled, we grew the BJ2168/pGES426-L-HSA cells to logarithmic phase, collected the cells, divided them into fractions and resuspended each fraction in medium supplemented with a different 3-AT concentration. The level of HSA expressed was proportional to the concentration of 3-AT provided up to 40 mM. Higher concentrations of 3-AT reduced the expression level of HSA ( Figure 4B ).
Expression of HSA from pGES Vectors Is Regulated at the Translational Level
To verify that the induction of HSA expression occurred at the translational level, we measured the levels of HSA mRNA and protein before and after induction with 3-AT ( Figure 5 ). Protein extracts were tested by Western blot analysis using anti-HSA antibodies ( Figure 5A ), while RNA preparations were subjected to primer extension analysis. The extended primers were separated on sequencing gels, which allowed accurate detection of each mRNA initiation site ( Figure 5 , B and C). As determined by Hinnebusch (14) , the transcription of GCN4initiates at three major sites (+1, +18 and +30) and at several minor sites, which gives rise to several mRNA species. Figure 5C shows that, as in the case of GCN4 mRNA, the HSAmRNA is expressed at a similar level before and after 3-AT is provided. Most initiation sites used by RNA polymerase to transcribe the GCN4 / HSA mRNA are identical to those found in GCN4mRNAs (compare Figure 5 press HSA is high ( Figure 4B ). The reason for this phenomenon is unknown to us. In contrast to the constitutive and uniform expression of the HSAmRNA, the HSA protein was barely detectable before induction with 3-AT, and its expression increased in time following induction. We conclude that 3-AT-dependent induction of HSA expression occurs at the translational level.
GCN4 -Based Vector Induces Efficient Expression as an Integrated Copy
The transcription rate of GCN4 seems to be high under most growth conditions in various strains and mutants (5, 14) . Accordingly, mRNA levels of HSAexpressed from pGES plasmids do not change significantly under different growth conditions ( Figure 5 and data not shown). We assume therefore that the efficient expression from the pGES426-L-HSA stems mainly from the efficient translation rate and less from the high copy number of the plasmid. If this is the case, we should be able to use the GCN4 / HSAcassettes as integrated copies. Cells carrying an integrated vector could be grown on YPD medium to high cell densities and produce high yields of HSA.
To test this possibility, we have inserted the GCN4 -L-HSAfragment into an integrative vector and thereby obtained the pGES306-L-HSA plasmid (see Materials and Methods). This construct was integrated into the yeast genome, and the resulting clones were grown on rich nonselective media to a high cell concentration (5 × 10 8 cells/mL) before the addition of 3-AT. Under these conditions, the expression of HSA was still efficiently induced ( Figure 6 ). The level of HSA obtained per cell was just slightly less than that obtained using the multicopy pGES426-L-HSA vector. However, as the culture grown on YPD reached higher cell concentration, the quantity of intracellular HSA protein obtained (about 0.5 mg/L) was about two times higher of that obtained with the multicopy plasmid pGES426-L-HSA. Notably, all experiments described in this study were performed on cultures grown in laboratory flasks, conditions that do not support maximal yields.
To compare the pGES vector to commonly used vectors, we have ligated the cDNA that encodes HSAdownstream from the ADH1promoter in the vector pAD4 ∆(1). Cultures that harbor either pADH-HSA or pGES426-L-HSA were grown in parallel, and the expression of HSA was compared. In the case of pGES426-L-HSA, expression was compared after induction. The levels of HSA expression obtained from both plasmids were similar. Using commercial purified HSA as a standard, we calculated that about 250 µ g/L of intracellular HSA were obtained in this experiment, about half of the amount obtained using the integrative version (pGES306-L-HSA) on rich medium. We conclude that the pGES system could be more efficient than currently available yeast expression vectors.
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BioTechniques 559 Figure 6 . pGES system is inducible in highly concentrated cultures. A culture harboring an integrated copy of pGES306-L-HSA was grown on YPD medium to A 600 = 3.3 when the medium was replaced with SD(-histidine) supplemented with 40 mM 3-AT. Samples were removed and analyzed by Western blot analysis at the indicated time points after induction. Purified HSA was loaded on the right lane of the gel.
Although pGES plasmids already seem quite efficient, they could be regarded as archetypes that could be further manipulated and improved. For example, it might be possible to increase the mRNA level of HSAthrough a combination of a strong constitutive promoter (of another gene) with the 5 ′ UTR of GCN4 . Such a chimera might be more efficient than pGES and still be translationally regulated. The regulation of GCN4translation is well studied, and mutants are available in which the GCN4translation rate is constitutively high and not regulated ( gcdmutants) (11, 14, 17) . Also, GCN4translation is induced by the yeast Ras/cAMP cascade and is high in RAS val19 and bcy1 strains (5). The pGES plasmids could be used in gcdstrains and in RAS2 val19 and bcy1strains as constitutive vectors. These ideas are only a few of the many ways in which the pGES vectors could be used to obtain large quantities of proteins for research and industry.
